"When I Don't Have a Cigarette It's Helpful, but It Really Don't Satisfy:" Qualitative Study of Electronic Nicotine Delivery Systems (ENDS) Use among Low-Income Smokers.
cigarettes
disparities
e-cigarettes
electronic nicotine delivery systems
income
qualitative
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
20 01 2022
20 01 2022
Historique:
received:
09
12
2021
revised:
06
01
2022
accepted:
13
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
3
3
2022
Statut:
epublish
Résumé
Little is known about the use of electronic nicotine delivery systems (ENDS) among low-income adult cigarette smokers, who experience severe tobacco-related health disparities. This study conducted interviews to examine experiences and perceptions associated with ENDS use among predominantly low-income adult smokers ( Overall, participants reported complementing rather than substituting their smoking with ENDS use (e.g., using ENDS only when smoking is not allowed). Predominant reasons for vaping were convenience, smoking reduction/cessation, stress management, social acceptability, lower long-term costs than smoking, and appealing flavors. Common reasons for not switching to exclusive vaping were that ENDS did not satisfy cigarette cravings and concerns about ENDS health effects. Participants indicated higher likelihood of switching to exclusive ENDS use if the products were more affordable, perceived as substantially less harmful, tasted and felt more like smoking a cigarette, and more effective for reducing cravings. Continued research is needed to maximize any harm reduction potential of ENDS and ensure that these products do not contribute to worsening health disparities.
Sections du résumé
BACKGROUND
Little is known about the use of electronic nicotine delivery systems (ENDS) among low-income adult cigarette smokers, who experience severe tobacco-related health disparities.
METHODS
This study conducted interviews to examine experiences and perceptions associated with ENDS use among predominantly low-income adult smokers (
RESULTS
Overall, participants reported complementing rather than substituting their smoking with ENDS use (e.g., using ENDS only when smoking is not allowed). Predominant reasons for vaping were convenience, smoking reduction/cessation, stress management, social acceptability, lower long-term costs than smoking, and appealing flavors. Common reasons for not switching to exclusive vaping were that ENDS did not satisfy cigarette cravings and concerns about ENDS health effects. Participants indicated higher likelihood of switching to exclusive ENDS use if the products were more affordable, perceived as substantially less harmful, tasted and felt more like smoking a cigarette, and more effective for reducing cravings.
CONCLUSIONS
Continued research is needed to maximize any harm reduction potential of ENDS and ensure that these products do not contribute to worsening health disparities.
Identifiants
pubmed: 35162181
pii: ijerph19031157
doi: 10.3390/ijerph19031157
pmc: PMC8834368
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA235719
Pays : United States
Références
Tob Control. 2014 Nov;23(e2):e133-8
pubmed: 24706085
PLoS One. 2018 Jul 9;13(7):e0198047
pubmed: 29985948
Addiction. 2016 Apr;111(4):724-33
pubmed: 26597453
Tob Control. 2019 Jan;28(1):42-49
pubmed: 29574448
Prev Chronic Dis. 2016 Jan 14;13:E07
pubmed: 26766848
Am J Health Behav. 2018 Sep 1;42(5):54-64
pubmed: 30688641
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Addict Behav. 2021 Jul;118:106909
pubmed: 33756301
Tob Control. 2021 Jan 21;:
pubmed: 33479031
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742
pubmed: 33211681
Qual Health Res. 2003 Jul;13(6):871-83
pubmed: 12891720
Tob Regul Sci. 2019 Nov;5(6):518-531
pubmed: 31696149
Tob Control. 2020 Mar;29(2):217-223
pubmed: 31040224
Drug Alcohol Depend. 2016 Feb 1;159:80-5
pubmed: 26708706
Prev Med. 2018 Sep;114:193-199
pubmed: 30026117
Am J Public Health. 2019 Sep;109(9):1224-1232
pubmed: 31318599
Tob Control. 2017 Dec;26(e2):e85-e91
pubmed: 28003324
Nicotine Tob Res. 2021 Mar 19;23(4):635-642
pubmed: 32803250
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052
Prev Med Rep. 2019 Nov 14;17:101020
pubmed: 31871881
Nicotine Tob Res. 2019 Apr 17;21(5):602-616
pubmed: 29608714
PLoS One. 2018 Jul 25;13(7):e0198681
pubmed: 30044773
JAMA. 2019 Dec 3;322(21):2132-2134
pubmed: 31688891
Tob Control. 2020 Mar;29(2):140-147
pubmed: 30760629
Prim Health Care Res Dev. 2018 Jul 02;20:e38
pubmed: 29961433
Harm Reduct J. 2018 Jun 20;15(1):31
pubmed: 29921278
Nicotine Tob Res. 2020 Apr 21;22(5):728-733
pubmed: 31298296
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
Addiction. 2020 Mar;115(3):518-526
pubmed: 31628817
Contemp Clin Trials. 2019 May;80:40-47
pubmed: 30904596
Am J Public Health. 2021 Feb;111(2):230-246
pubmed: 33351653
JAMA Netw Open. 2018 Jul 6;1(3):e180789
pubmed: 30646032
BMJ Open. 2017 Apr 1;7(4):e013079
pubmed: 28365587
MMWR Morb Mortal Wkly Rep. 2013 Jul 5;60(53):1-117
pubmed: 23820934
Ann N Y Acad Sci. 2012 Feb;1248:107-23
pubmed: 22092035
JAMA Netw Open. 2020 Jun 1;3(6):e206436
pubmed: 32492162
Addiction. 2021 Mar;116(3):596-605
pubmed: 33463849
Health Behav Policy Rev. 2016 Nov;3(6):590-596
pubmed: 28393082
Nicotine Tob Res. 2015 Oct;17(10):1242-6
pubmed: 25744966
BMC Public Health. 2015 Sep 04;15:859
pubmed: 26341634
J Consult Clin Psychol. 1991 Apr;59(2):295-304
pubmed: 2030191
Cochrane Database Syst Rev. 2021 Apr 29;4:CD010216
pubmed: 33913154
Drug Alcohol Depend. 2020 Jun 1;211:107855
pubmed: 32057533
Nicotine Tob Res. 2021 Oct 7;23(11):1831-1838
pubmed: 34089607
Nicotine Tob Res. 2015 Oct;17(10):1187-94
pubmed: 25896067
Am J Med. 2019 Aug;132(8):949-954.e2
pubmed: 30853474
Nicotine Tob Res. 2019 Sep 19;21(10):1363-1370
pubmed: 29917124
Addict Behav. 2021 Aug;119:106939
pubmed: 33894482
Prev Med. 2020 Nov;140:106145
pubmed: 32473270
Lancet Respir Med. 2015 Aug;3(8):598-600
pubmed: 26116291
Addict Behav. 2019 Jun;93:194-197
pubmed: 30735829
Nicotine Tob Res. 2020 Apr 21;22(5):843-847
pubmed: 30312465
Nicotine Tob Res. 2019 Sep 19;21(10):1385-1393
pubmed: 29986109
Health Psychol. 2010 May;29(3):262-73
pubmed: 20496980